Peter A. Thompson - Insider Trading & Ownership

Entity
Individual
Location
C/O Anthera Pharmaceuticals, Inc., 25801 Industrial Boulevard, Suite B, Hayward, CA
Summary
The estimated net worth of Peter A. Thompson is at least $242M dollars as of August 28, 2024. Peter A. Thompson is the Director, 10%+ Owner of Edgewise Therapeutics, Inc. and owns shares of Edgewise Therapeutics, Inc. (EWTX) stock worth about $228M. Peter A. Thompson is the Director, 10%+ Owner of Corvus Pharmaceuticals, Inc. and owns shares of Corvus Pharmaceuticals, Inc. (CRVS) stock worth about $14.5M.
All Insider Reports
All Insider Reports

Ownership of Peter A. Thompson

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
EWTX Edgewise Therapeutics, Inc. Director, 10%+ Owner $228M +$5M +2.24% Jun 10, 2024
CRVS Corvus Pharmaceuticals, Inc. Director, 10%+ Owner $14.5M +$2.5M +20.8% Jun 13, 2024
ALPN ALPINE IMMUNE SCIENCES, INC. Director $0 -$28.7M -100% May 18, 2024
SPRY ARS Pharmaceuticals, Inc. Director $0 -$12.6M -100% Aug 26, 2024
DBTX Decibel Therapeutics, Inc. Director, 10%+ Owner Jun 17, 2022
JANX Janux Therapeutics, Inc. Director Jun 14, 2022
PMVP PMV Pharmaceuticals, Inc. Director, 10%+ Owner Jun 2, 2021

Insider Transactions Reported by Peter A. Thompson:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.